Wird geladen...
LIPOSOMAL SIRNA NANOCARRIERS FOR CANCER THERAPY
Small interfering RNAs (siRNA) have recently emerged as a new class of therapeutics with a great potential to revolutionize the treatment of cancer and other diseases. A specifically designed siRNA binds and induces post-transcriptional silencing of target genes (mRNA). Clinical applications of siRN...
Gespeichert in:
| Veröffentlicht in: | Adv Drug Deliv Rev |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2013
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4527165/ https://ncbi.nlm.nih.gov/pubmed/24384374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.addr.2013.12.008 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|